Scholars Central

Conference abstract

Nanoparticles for Protein delivery: Improving efficacy, reducing Protein diffusion, and reducing tissue overgrowth

Authors: Esmaiel Jabbari

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Proteins play a major role in initiating the cascade of cell differentiation and maturation in regenerative medicine. However, high doses of the exogenous protein coupled with its diffusion away from the site of regeneration cause adverse side effects. In particular, recombinant human bone morphogenetic protein-2 (BMP2) used clinically in spine fusion, plays a major role in initiating the cascade of chemotaxis, differentiation of bone marrow mesenchymal stem cells (MSCs) and bone regeneration. However, high doses coupled with protein diffusion cause adverse effects such as bone overgrowth, immunological reaction, and tumorigenesis. In an effort to reduce the protein dose, diffusion, and side effects, our laboratory has pioneered to use of nanotechnology, specifically nanoparticles (NPs), for more efficient delivery of growth factors. In this approach, the protein or the amino acid sequence based on the active domain of the protein is grafted to NPs prior to applying to the regeneration site. The grafting to NPs reduces the diffusion of the protein away from the regeneration site, provides a source for sustained release of the protein in the case of biodegradable, and provides a multivalent form of the protein for stronger interaction with cell surface receptors, leading to longer- term and more efficient protein delivery with fewer side effects. We will demonstrate that the expression of differentiation markers of MSCs supplemented with BMP2 grafted NPs is significantly higher than those directly treated with BMP2. We believe this is related to a more effective presentation of the protein to clustered cell surface receptors

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nanomedicine & Nanotechnology
  • SubjectNanotechnology
  • BylineArticles whose byline prints “Esmaiel Jabbari”